Approval received from NABL/ICMR to carry out COVID-19 testing in India.
Contact: +91-20-48566661

Oncology (Solid Tumors)

Test No. Test Name Analytical Technique Sample required TAT
ONCNGS168 BRAF V600 region sequencing NGS Paraffin block/ Fresh tissue 4-5 weeks
ONCNGS160 KRAS mutation analysis (codons 12, 13, 61 & 146) by NGS NGS Paraffin Block/ Fresh tissue 4-5 weeks
ONCNGS158 EGFR mutation analysis (exons 18, 19, 20 and 21) by NGS NGS Paraffin Block/ Fresh tissue 4-5 weeks
ONCNGS387 EGFR T790M Quantitative mutation detection by NGS NGS Paraffin Block/ Fresh tissue 4-5 weeks
ONCNGS236 EGFR (exons 18, 19, 20 and 21) and KRAS (codons 12, 13, 61 and 146) ultradeep mutation analysis by Next Generation Sequencing NGS Paraffin Block/ Fresh tissue 4-5 weeks
ONCNGS045 BRCause NGS Panel - Full sequencing of BRCA1 and BRCA2 NGS Blood in EDTA 4-5 weeks
ONCNGS046 BRCause Extended NGS Panel - Full sequencing of BRCA1, BRCA2, ATM, BRIP1, NBN, RAD51C, RAD51D, PALB2, STK11, CHEK2, PTEN, TP53, CDH1, MLH1, MSH2, MSH6, PMS2, APC, SMAD4, BLM, FANCC, ERCC2 and EPCAM genes NGS Blood in EDTA 4-5 weeks
ONCMLP203 BRCopy: BRCA1, BRCA2 copy number variations and large gene rearrangements MLPA Blood in EDTA 10 days
ONCNGS393 Germline panel for FAP (Familial Adenomatous Polyposis) (Next Generation Sequencing of APC, MUTYH genes) NGS Blood in EDTA 4-5 weeks
ONCNGS241 Germline Panel for Hereditary Non-polyposis Colorectal Carcinoma (HNPCC)/ Lynch Syndrome (Next Generation Sequencing of EPCAM, MLH1, MSH2, MSH6 and PMS2) NGS Blood in EDTA 4-5 weeks
ONCNGS244 Next Generation Sequencing panel for Multiple Endocrine Neoplasia (MEN) including RET and MEN1 genes NGS Blood in EDTA 4-5 weeks
ONCNGS248 Retinoblastoma (RB1 gene Next Generation Sequencing) NGS Blood in EDTA 4-5 weeks
ONCFRG429 Microsatellite Instability (MSI) by Fragment analysis Fragment Analysis FFPE Blocks/ Tissue + Blood in EDTA 2 weeks
ONCMLP389 MLPA for Von Hippel Lindau (VHL) Syndrome MLPA Blood in EDTA 10 days
NEPSEQ272 Von Hippel Lindau Syndrome (Sequencing of exons 1, 2 and 3 of the VHL gene) CE-Seq Blood in EDTA 2-3 weeks
ONCSEQ399 Targeted sequencing in VHL, gene (for family members at risk) CE-Seq Blood in EDTA 2 weeks
INDHC2440 Human Papillomavirus (HPV) testing for Cervical Cancer Risk by HC2 Hybrid Capture 2 Cervical specimen in SurePath collection vial Every Thursday
INDNGS441 Human Papillomavirus (HPV) genotyping by NGS (RUO) NGS Cervical specimen in SurePath collection vial 4-5 weeks